Possible role of matriptase in the diagnosis of ovarian cancer

被引:20
作者
Johnson, MD [1 ]
Oberst, MD
Lin, CY
Dickson, RB
机构
[1] Georgetown Univ, Med Ctr, Vincent T Lombardi Canc Res Ctr, Dept Oncol, Washington, DC 20057 USA
[2] NCI, Canc Res Ctr, Cell & Canc Biol Branch, Bethesda, MD 20892 USA
[3] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20057 USA
关键词
diagnosis; HAI-1; matniptase; ovarian cancer; screening;
D O I
10.1586/14737159.3.3.331
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
There are increasing data that suggest a role for the serine protease matriptase and its inhibitor, hepatocyte growth factor activator inhibitor-1, in the pathogenesis and progression of ovarian cancer. This review will discuss the matriptase/inhibitor system in the context of ovarian cancer and examine the possibility that this system might be a useful therapeutic and/or diagnostic target in this disease.
引用
收藏
页码:331 / 338
页数:8
相关论文
共 69 条
[1]  
[Anonymous], 1994, Gynecol Oncol, V55, pS4
[2]   THE DROSOPHILA STUBBLE-STUBBLOID GENE ENCODES AN APPARENT TRANSMEMBRANE SERINE-PROTEASE REQUIRED FOR EPITHELIAL MORPHOGENESIS [J].
APPEL, LF ;
PROUT, M ;
ABUSHUMAYS, R ;
HAMMONDS, A ;
GARBE, JC ;
FRISTROM, D ;
FRISTROM, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (11) :4937-4941
[3]   Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase [J].
Benaud, C ;
Oberst, M ;
Hobson, JP ;
Spiegel, S ;
Dickson, RB ;
Lin, CY .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) :10539-10546
[4]   Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor [J].
Benaud, C ;
Dickson, RB ;
Lin, CY .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (05) :1439-1447
[5]   Deregulated activation of matriptase in breast cancer cells [J].
Benaud, CM ;
Oberst, M ;
Dickson, RB ;
Lin, CY .
CLINICAL & EXPERIMENTAL METASTASIS, 2002, 19 (07) :639-649
[6]   Dedifferentiation of serous ovarian cancer from cystic to solid tumors is associated with increased expression of mRNA for urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor (PAI-1) [J].
Borgfeldt, C ;
Hansson, SR ;
Gustavsson, B ;
Måsbäck, A ;
Casslén, B .
INTERNATIONAL JOURNAL OF CANCER, 2001, 92 (04) :497-502
[7]  
CHAMBERS SK, 1995, CANCER, V75, P1627, DOI 10.1002/1097-0142(19950401)75:7<1627::AID-CNCR2820750712>3.0.CO
[8]  
2-V
[9]  
Chambers SK, 1998, INT J CANCER, V79, P449
[10]   N-terminal processing is essential for release of epithin, a mouse type II membrane serine protease [J].
Cho, EG ;
Kim, MG ;
Kim, C ;
Kim, SR ;
Seong, IS ;
Chung, CH ;
Schwartz, RH ;
Park, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (48) :44581-44589